Skip to main content

OZURDEX dexamethasone 700 microgram intravitreal implant, Allergan Australia Pty Ltd, CON-879

Product name
OZURDEX dexamethasone 700 microgram intravitreal implant
Sponsor name
Allergan Australia Pty Ltd
Consent start
Consent no.
CON-879
Standard
Paragraph 9(3)(a) and Subsection 9(5) of Therapeutic Goods Order No. 91 '“ Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The product does not conform to the requirements of Paragraph 9(3)(a) and Subsection 9(5) of Therapeutic Goods Order No. 91 '“ Standard for labels of prescription and related medicines (TGO 91), in that the product does not have the name and quantity of the active ingredient printed immediately below the name of the medicine on the applicator pen label, and are printed in a text size less than 3.0 millimetres in size.
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site